Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Angiogenesis prostate cancer

Two recent MAbs have been approved by the FDA to treat prostate cancer and macular degeneration through the use of the antibodies to target VEGF and stop angiogenesis (Exhibit 4.12). [Pg.120]

Collado B, Sanchez MG, Diaz-Laviada I, Prieto JC, Carmena MJ. 2005. Vasoactive intestinal peptide (VIP) induces c-fos expression in LNCaP prostate cancer cells through a mechanism that involves Ca2 + signalling. Implications in angiogenesis and neuroendocrine differentiation. Biochim Biophys Acta 1744 224-233. [Pg.388]

Shankar S, Chen Q, Sarva K, Siddiqui I, Srivastava RK. 2007. Curcumin enhances the apoptosis-inducing potential of TRAIL in prostate cancer cells Molecular mechanisms of apoptosis, migration and angiogenesis. J Mol Signal 2 10. [Pg.395]

Ryan CJ, Lin AM, Small EJ. Angiogenesis inhibition plus chemotherapy for metastatic hormone refractory prostate cancer history and rationale. Urol Oncol. 2006 24 250-253. [Pg.589]

Moul, J.W. 1999. Angiogenesis, p53, bcl-2 and Ki-67 in the progression of prostate cancer after radical prostatectomy. Eur. Urol. 35, 399-407. [Pg.159]

Strohmeyer, D., Rossing, C., Bauerfeind, A., Kaufmann, O., Schlechte, H., Bartsch, G., andlxrening, S. 2000. Vascular endothelial growth factor and its correlation with angiogenesis and p53 expression in prostate cancer. Prostate 45, 216-224. [Pg.163]

Ali I, Senger D, Smith L. Angiogenesis as a potential biomarker in prostate cancer chemoprevention trials. Urology 2001 57 143-147. [Pg.219]

W7. Wikstrom, P., Stattin, P., Franck-Lissbrandt, I., Damber, J. E., and Bergh, A., Transforming growth factor beta 1 is associated with angiogenesis, metastasis, and poor outcome in prostate cancer. Prostate 37, 19-29 (1998). [Pg.159]

Dorai, T., Cao, Y.C., Dorai, B., Buttyan R., and Katz, A.E., Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo, Prostate, M, 293, 2001. [Pg.191]

TNF-u is a powerful. stimulant to angiogenesis. The secretion of this factor by macrophages in prostatic cancers is decreased significantly by linomidc. a quinolinc-.1-carboxa-midc derivative. ... [Pg.447]

Silberman MA, Partin AW, Veltri RW, Epstein JI. Tumor angiogenesis correlates with progression after radical prostatectomy but not with pathologic stage in Gleason sum 5 to 7 adenocarcinoma of the prostate. Cancer. 1997 79 772. [Pg.654]

Strohmeyer D, Rossing C, Strauss E, et al. Tumor angiogenesis is associated with progression after radical prostatectomy in pT2/ pT3 prostate cancer. Prostate. 2000 42 26. [Pg.654]

Ferrer, F. A., Miller, L. J., et al. (1998). Angiogenesis and prostate cancer in vivo and in vitro expression of angiogenesis factors by prostate cancer cells. Urology 51(1) 161-7. [Pg.25]

Kim, S.J., H. Uehara, T. Karashima, M. McCarty, N. Shih, and I.J. Fidler. Expression of interleukin-8 correlates with angiogenesis, tumorigenicity, and metastasis of human prostate cancer cells implanted orthotopically in nude mice. Neoplasia 3 33-42, 2001. [Pg.146]

Role of Chemokines and Their Receptors in Prostate Cancer Angiogenesis and Tumor Growth... [Pg.154]

See other pages where Angiogenesis prostate cancer is mentioned: [Pg.328]    [Pg.457]    [Pg.469]    [Pg.930]    [Pg.308]    [Pg.357]    [Pg.931]    [Pg.529]    [Pg.318]    [Pg.67]    [Pg.172]    [Pg.177]    [Pg.22]    [Pg.148]    [Pg.224]    [Pg.17]    [Pg.409]    [Pg.186]    [Pg.2039]    [Pg.286]    [Pg.139]    [Pg.618]    [Pg.4]    [Pg.8]    [Pg.9]    [Pg.50]    [Pg.52]    [Pg.135]    [Pg.136]    [Pg.138]    [Pg.147]    [Pg.154]    [Pg.155]    [Pg.156]    [Pg.157]   
See also in sourсe #XX -- [ Pg.154 , Pg.155 , Pg.156 ]



SEARCH



Angiogenesis

Cancer angiogenesis

Cancer, prostat

Prostate cancer

Prostatic cancer

© 2024 chempedia.info